Beyond the Pandemic Era: Recent Advances and Efficacy of SARS-CoV-2 Vaccines Against Emerging Variants of Concern
Vaccines,
Год журнала:
2025,
Номер
13(4), С. 424 - 424
Опубликована: Апрель 17, 2025
Vaccination
has
been
instrumental
in
curbing
the
transmission
of
SARS-CoV-2
and
mitigating
severity
clinical
manifestations
associated
with
COVID-19.
Numerous
COVID-19
vaccines
have
developed
to
this
effect,
including
BioNTech-Pfizer
Moderna’s
mRNA
vaccines,
as
well
adenovirus
vector-based
such
Oxford–AstraZeneca.
However,
emergence
new
variants
subvariants
SARS-CoV-2,
characterized
by
enhanced
transmissibility
immune
evasion,
poses
significant
challenges
efficacy
current
vaccination
strategies.
In
review,
we
aim
comprehensively
outline
landscape
emerging
concern
(VOCs)
sub-lineages
that
recently
surfaced
post-pandemic
years.
We
assess
effectiveness
existing
their
booster
doses,
against
these
subvariants,
BA.2-derived
sub-lineages,
XBB
BA.2.86
(Pirola).
Furthermore,
discuss
latest
advancements
vaccine
technology,
multivalent
pan-coronavirus
approaches,
along
development
several
next-generation
coronavirus
exosome-based,
virus-like
particle
(VLP),
mucosal,
nanomaterial-based
vaccines.
Finally,
highlight
key
critical
areas
for
future
research
address
evolving
threat
develop
strategies
combating
viral
threats,
thereby
improving
preparedness
pandemics.
Язык: Английский
Viral Infections in Elderly Individuals: A Comprehensive Overview of SARS-CoV-2 and Influenza Susceptibility, Pathogenesis, and Clinical Treatment Strategies
Vaccines,
Год журнала:
2025,
Номер
13(4), С. 431 - 431
Опубликована: Апрель 21, 2025
As
age
increases,
the
immune
function
of
elderly
individuals
gradually
decreases,
increasing
their
susceptibility
to
infectious
diseases.
Therefore,
further
research
on
common
viral
infections
in
population,
especially
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
and
influenza
viruses,
is
crucial
for
scientific
progress.
This
review
delves
into
genetic
structure,
infection
mechanisms,
impact
coinfections
with
these
two
viruses
provides
a
detailed
analysis
reasons
increased
dual
infections.
We
evaluated
clinical
manifestations
following
coinfections,
including
complications
respiratory,
gastrointestinal,
nervous,
cardiovascular
systems.
Ultimately,
we
have
summarized
current
strategies
prevention,
diagnosis,
treatment
SARS-CoV-2
older
adults.
Through
studies,
aim
reduce
risk
provide
basis
age-related
diseases,
thereby
improving
health
status.
Язык: Английский